Eventide Asset Management’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,675,959
| Closed | -$3.27M | – | 140 |
|
|
2023
Q1 | $3.27M | Sell |
1,675,959
-204,000
| -11% | -$398K | 0.06% | 131 |
|
|
2022
Q4 | $7.22M | Hold |
1,879,959
| – | – | 0.14% | 119 |
|
|
2022
Q3 | $9.06M | Hold |
1,879,959
| – | – | 0.18% | 106 |
|
|
2022
Q2 | $14.9M | Sell |
1,879,959
-95,041
| -5% | -$756K | 0.32% | 81 |
|
|
2022
Q1 | $29M | Hold |
1,975,000
| – | – | 0.45% | 67 |
|
|
2021
Q4 | $39.9M | Buy |
1,975,000
+663,010
| +51% | +$13.4M | 0.51% | 68 |
|
|
2021
Q3 | $35.6M | Hold |
1,311,990
| – | – | 0.47% | 69 |
|
|
2021
Q2 | $31.9M | Buy |
1,311,990
+397,251
| +43% | +$9.67M | 0.43% | 70 |
|
|
2021
Q1 | $22.3M | Sell |
914,739
-160,261
| -15% | -$3.91M | 0.33% | 89 |
|
|
2020
Q4 | $34.4M | Buy |
1,075,000
+494,517
| +85% | +$15.8M | 0.53% | 61 |
|
|
2020
Q3 | $19.2M | Buy |
580,483
+430,483
| +287% | +$14.2M | 0.37% | 76 |
|
|
2020
Q2 | $7.02M | Buy |
+150,000
| New | +$7.02M | 0.15% | 99 |
|